X

Cell line references

Proven performance

Find the best model for your cancer research. Our cell line references tool quickly displays Envigo oncology models and independent peer-reviewed publications to ensure you can make informed model decisions about your research.

View Cell Line by

Filter by

Human Tissue
Cancer Stem Cells (Human Tissue)
Rodent Tissue
Patient-Derived Tumors (Human Tissue)

Hover over the reference to see the article that links to the peer-reviewed publication. Click on the rodent model to the right of the cell line to be taken to that model page.

Cell Line Mice Rats
Bladder
KU-7 148, 149, 150, 151 nude
T24 52 nude
UM-UC1 278 nude
UM-UC13 278 nude
UM-UC3 278 nude
Bladder
AY-27 357 fischer 344
Bladder (rat)
NBT-II 299 nude nude
Brain
A-172 198 nude
G55 3 nude
GL15 286 c.b-17 scid
GS-11 397 shrn®
HTLA-230 5, 125 scid-beige, nude
SH-SY5Y 2 nude
T87 GSC 400 nude
TB10 200 nude
U138MG 203, 266 nod.scid, nude
U251 81, 202 nude
U251 MG 198, 199 nude
U251-NG2 1, 285 nude
U373 207 nude
U87 71, 81, 117, 173, 196 nmri nude, nude, scid
U87ΔEGFR 197 nude mice
U87Fluc 79, 82 balb/c nude, nude
U87MG 4, 78, 80, 83, 133, 134, 164, 195, 198, 201, 205, 206, 209, 224, 249, 342, 404 balb/c scid, beige-nude-xid, cd-1 nude, nmri nude, nude, scid nude
U87MG.wt EGFR 203 nude mice
U87-TARTK 208 nod.scid
Brain
BTSC83 200 nude
Glioblastoma 331, 341, 343 nod.scid, nude
LA-N-5 231 nude
NGC-407-GFP 206 nude
U87-SC 232 nude
Brain
RT2-GFP 356 fischer 344
Tu-2449 365 b6c3f1
Brain
(PDX) 271 nude
U87MG (GBM PDX) 337 nude
Brain (rat glioma)
C6 58, 59, 78, 140, 180 nod.scid, nude
Breast
231/LM2-4 353 nude
BT-474 61, 62, 72, 143, 157, 160, 161, 162, 163, 165, 211, 227, 228, 258, 270 balb/c nude, nude, c.b-17 scid, scid-beige
BT-474/TR 161, 162 nude
BT-474C 299 nude nude
BT474-EEI 252 beige-nude-xid
BT-474-M1 178, 253, 254, 257, 288 beige-nude-xid, nude, scid
HCC1569 162 nude
JIMT-1 68, 69, 226, 289 c.b-17 scid, nmri nude, nude, scid
KPL-4 143 nude, scid-beige
MCF/HER2-18 160 nude
MCF-7 8, 14, 24, 97, 103, 128, 130, 131, 132, 138, 143, 146, 192, 210, 217, 218, 219, 226, 229, 230, 255, 256, 290, 308, 309, 310, 311, 312, 313, 354 balb/c nude, cd-1 nude, mf1 nude, nude, scid, scid-beige, shrn® nude
MCF-GFP 349 nude
MCF-RSK4 349 nude
MDA-IBC3 401 scid-beige
MDA-MB-175 253 beige-nude-xid
MDA-MB-231 9, 11, 12, 15, 56, 71, 94, 111, 116, 136, 139, 143, 156, 174, 176, 177, 184, 185, 186, 187, 188, 189, 190, 191, 193, 209, 217, 267, 287, 299, 354 balb/c scid, cd-1 nude, nude, nod.scid, scid, scid-beige, shrn® nude
MDA-MB-231-mCherry 282 nude
MDA-MB-361 60, 256, 313 nude
MDA-MB-435 12 nude
MDA-MB-453 158, 256 nude
MDA-MB-468 226, 260, 266 nude, nod.scid, scid
MEF-p95-HER2 64 nude
MT-1 13, 170, 245 cd-1 nude, nude nude
SUM149 401 scid-beige
T47D 6, 7, 130, 210, 229, 259, 310, 313, 402 balb/c nude, nude, scid-beige
ZR-75-1 299 nude nude
Breast
2LMP (MDA-MB-231 subclone) 234 nod.scid
BCM-2147 340 scid-beige
BCM-2665 340 scid-beige
BCM-3887 340 scid-beige
BCM-4195 340 scid-beige
MCF-7 (CSC-like) 236 nude
MCF-7 (mammospheres) 235 nude
SUM159 234 nod.scid
Breast
4T07 403 balb/c
4T1 379, 381, 382, 390 balb/c
4T1-luc2 366 balb/c
JC 384 c57bl/6j, balb/c
P53-null MECs 390 balb/c
Breast
BMC-2147 274 scid-beige
HBCX 1 270 nude
HBCX 12B 270 nude
HBCX 17 270 nude
HBCX 6 270 nude
HBCX 7 270 nude
HBCX 9 270 nude
HBCx-24 339 balb/c nude
HBCx-3 339 balb/c nude
HBCx-30 339 balb/c nude
HBCx-4A 339 balb/c nude
HBCx-8 339 balb/c nude
MC1 274 scid-beige
PDX156 349 nmri nude
PDX60 349 nmri nude
TNBC (MC1) 273 nod.scid
Carcinoma
B4B8 388 balb/c
LY2 388 balb/c
Cervical
HeLa 78, 124, 344, 346, 347 nude nude
Hep-2 (HeLa contaminant) 345 balb/c nude
ME-180 291 nude
SiHa 291 nude
Colon
BCS-TC2.2 113 nude
Colo201 338 nude
Colo205 180, 299 nude, nod.scid nude
Colo320 113 nude
Colo320-CD9 113 nude
GEO 143, 258, 338 nude, scid-beige
HCA-7 17 nude
HCT-15 338 nude
LoVo 116, 299 nude nude
LS174T 63, 140, 159, 392 nude
LS411N 392 nude
MV522 180 nude, nod.scid
SW403 392 nude
SW480 122 scid
Colon
AOM-induced colon tumors 358, 359, 364 fischer 344
CT26 367, 369, 380, 383, 386, 391 c57bl/6, balb/c
CT26 391 balb/c
CT26CL25 385 balb/c
Colorectal
CX-1 20 nude
DLD-1 16, 152, 243, 294 nude
HCT-116 17, 18, 19, 112, 143, 153, 164 nude, scid, scid-beige
HT-29 16, 22, 23, 114, 115, 116, 117, 141, 143, 147, 239, 263, 295, 299, 347 balb/c nude, beige-nude-xid, nmri nude, nude, scid-beige nude
SW620 243, 294 nude
Colorectal
AOM-induced colon tumors 362 fischer 344
Colorectal
(BRAF mutant PDX) 332 nmri nude
(KRAS mutant PDX) 332 nmri nude
(PIK3CA mutant PDX) 332 nmri nude
(PTEN mutant PDX) 332 nmri nude
CUCRC006 338 nude
CUCRC026 338 nude
CUCRC036 338 nude
CUCRC040 (KRAS mutant PDX) 336 nude
CUCRC042 338 nude
CUCRC042 (KRAS/PIK3CA mutant PDX) 336 nude
CUCRC047 338 nude
CUCRC108 (KRAS mutant PDX) 336 nude
CUCRC125 336 nude
Embryo (murine)
Src3T3 299 nude nude
Endometrial
ECC-1 312 nude
Esophageal
FLO-1 172 nude
OE19 126, 127, 138, 154, 175 balb/c nude, mf1 nude, nude, scid
OE21 154 nude
OE33 154, 155, 172 nude
OE47 154 nude
Esophageal
NMBA-induced esophageal tumors 360, 361 fischer 344
Fibrosarcoma
HT1080 77, 124, 209 balb/c scid, nude
Gastric
MKN45 124 nude
N87 70, 143, 164, 175, 258 nmri nude, nude, scid, scid-beige
Head & Neck Squamous Cell Carcinoma (HNSCC)
Cal-27 65, 66, 67 nude
CCL 23 (HeLa contaminant) 67 nude
FaDu 21, 65, 244 nude nude
HeLa-O3 330 nude
HNX-OE 21 nude
SCC-1 284 nude
SCC1 (cetuximab-resistant) 395 nude
SCC1483 395 nude
UM-SCC1 66, 67, 116, 284 nude
UMSCC38 279 nude
WSUHN-31 60 nude
Kidney
(Renal Cell Carcinoma PDX) 393 nude
Leukemia
ARH-77 298 c.b-17 scid
HEL9217 57 c.b-17 scid
HL60 57, 171 c.b-17 scid
HPB-ALL 27 nude
K562 171, 396 c.b-17 scid, shrn®
KG-1 144 c.b-17 scid
MV4-11 166, 179, 180, 181, 182, 296, 348 nod.scid, nude nude
TF1-α 57 c.b-17 scid
THP-1 75 c.b-17 scid
Liver
AKH10 307 scid-beige
Hep3B 25, 101, 119, 137, 222, 223, 225, 392 nude nude
Hep-G2 122 scid
HepT1 25 nude
HuCCT1 262 nude
HuH6 26 nude
Huh-7 122 scid
KFJ10 307 scid-beige
KFJ6 307 scid-beige
KFJ9 307 scid-beige
Liver
MC38-Luc1 387 c57bl/6
Liver
AKH23 307 scid-beige
KFJ18 307 scid-beige
Lung
A549 9, 11, 15, 33, 109, 110, 117, 122, 143, 183, 244, 258 nmri nude, nude, scid, scid-beige nude
A549m 279 nude
BEN 88 scid-beige
Calu6 142, 143, 299 nod.scid, scid-beige, nude nude
Colo-699 34, 88, 89 scid-beige
H226 (NSCLC) 395 nude
H226B 279 nude
H358 31 nude
KNS-62 34, 88, 89 scid-beige
L2987 143 scid-beige, nude
LX-1 143 scid-beige, nude
NCI-H460 114, 225, 293, 297 c.b-17 scid, nude nude
NCI-H69 143, 354 nude, scid-beige, shrn®
NCI-H82 118 nude
NCI-H841 354 shrn®
NCI-N417 32 nude
PC-9/BRc1 351 nude
Lung
A549 108 nude
H1299 108 nude
Lung
(NSCLC PDX) 272 nod.scid
p2 SCLC PDXact 354 nod.scid
Lung (murine)
LL2 10 nude
Lung Cancer
LL 371 c57bl/6
Lymphoma
CA46 144 scid
Granta 30, 144 scid
Karpas-299 28, 90 scid
L540cy 28 scid
MUTU-1 398 c.b-17 scid
SP53 30 scid
Z138 238 scid
Lymphoma
E.G7 384 c57bl/6j, balb/c
E.G7-OVA 373 c57bl/6
EL4 367, 371 c57bl/6, balb/c
Lymphoma (non-Hodgkin's)
Raji 120, 121, 182 nod.scid, scid
Mammary
MNU-induced mammary tumors 363 sprague dawley
Mammary (rat)
17β-estradiol-induced mammary tumors 355 brown norway
DMBA-induced rat mammary carcinoma 301 nude
Melanoma
518A2 122, 247, 319, 321 c.b-17 scid, scid
537MEL 323 beige-nude-xid
607B 247 scid
A2058 318 scid
A375 163, 281, 306, 316 nude
A375M 249 nude
DM6 85 nude
FM82 320 nod.scid
Ge 248 scid-beige
Mel-JUSO 247 scid
MelM9 322 c.b-17 scid
NIH1286 84 nude
SIT1 37 scid
SK-MEL23 323 beige-nude-xid
UACC 315 nude
VM 317 balb/c scid
Melanoma
B16 367, 369, 378 c57bl/6, balb/c
B16.F10 375 c57bl/6
B16.OVA 373 c57bl/6
B16-F10 368, 370 c57bl/6
B16-OVA 372, 375 c57bl/6
Melanoma (murine)
B16F10 35, 36, 250, 392 beige-nude-xid, nude
Mesothelioma
DEVy 100 nude
Multiple Myeloma
ARP-1 144 scid
KAS-6/1 76 scid
L-363 120 scid
LAGΛ-1 74, 75 nude
MM.1S 120, 144, 399 c.b-17 scid, scid
MPC-11 325 beige-nude-xid
NCI-H929 242 nod.scid
RPMI 303, 304, 305 c.b-17 scid, scid
U266 242 nod.scid
Oral
686LN 279 nude
KB (HeLa contaminant) 299 nude nude
Oral
(Floor of Mouth Squamous Cell Carcinoma PDX) 395 nude
Osteosarcoma
143B-Luc 405 nude
Ovarian
1A9 78 nude
1A9ptx10 78 nude
A2780 143, 350 nude, scid-beige
CAOV3 87 nude
CD228 143 nude, scid-beige
HEY 269 nude
MW387 143 nude, scid-beige
NMP-1 96 nude
OVA-1 91 scid
OVCAR-3 39, 73, 98, 99 nmri nude, nude
PA354 143 nude, scid-beige
SKOV-3 38, 40, 41, 55, 86, 92, 93, 95, 211, 212, 213, 214, 292, 324 balb/c nude, beige-nude-xid, nude, scid nude
SKOV3-luc 237 nude
Ovarian
A2780-CR5 [ALDH(+) and ALDH(-)] 350 nude
SKOV-3 (spherical cells) 213 balb/c nude
Ovarian (rat)
PROb 78 nude
Pancreatic
AsPC-1 299 nude nude
Bx/shRON 276 nude
BxPC-3 42, 275, 276 nude
BxPC3/shSTAT3 280 nude
BxPC3/vector 276, 280 nude
CFPAC-1 43, 394 nude
CFPAC-1 394 nude
Colo357 42, 44, 251 nude, scid-beige
HPAC 299 nude nude
L3.6pl 123, 236 nude
MIA PaCa-2 54, 167, 277 nude
MIA-Luc 202 nude
PANC-1 42, 167, 168 nude
Panc185 272 nude
Panc430 262 nude
Panc89 45 scid
PL45 43 nude
T3M4 42 nude
Pancreatic
Panc02 367, 374, 377 c57bl/6, balb/c
Pancreatic
JH033 272 nude
Panc194 335 nude
Prostate
CWR22 51, 143 nude, scid-beige
DU-145 29, 211, 221 icr-scid, nude
LAPC4 107, 352 nude
LNCaP 50, 104, 105, 106, 194, 223, 246, 326 nude, c.b-17 scid, scid
LuCap35 143 nude, scid-beige
MDA-PCa-2b 143 nude, scid-beige
PC-3 46, 47, 48, 49, 129, 135, 138, 143, 169, 209, 211, 216, 220, 240, 246, 283, 302 balb/c nude, balb/c scid, beige-nude-xid, mf1 nude, nude, scid, scid-beige
PC-3M 164 nude
VCaP 215 nude
Prostate
DU-145 (spheroid cells) 233 nod.scid
Prostate
Tgfbr2floxE2 376 c57bl/6
Prostate
1B 333 nude
2B 333 nude
2T 333 nude
3B 333 nude
3T 333 nude
4B 333 nude
4T 333 nude
Renal
786O 127, 138, 180 balb/c nude, mf1 nude, nod.scid, nude
ACHN 328 nod.scid
Caki-2 329 nude
Retinoblastoma
Y79 241 nude
Sarcoma
(Chondrosarcoma PDX) 334 nude
(Ewing sarcoma PDX) 334 nude
(Leiomyosarcoma PDX) 334 nude
(Liposarcoma PDX) 334 nude
(Multifocal sarcoma PDX) 334 nude
(Myxoma PDX) 334 nude
(Phyllodes sarcoma PDX) 334 nude
(Rhabdomyosarcoma PDX) 334 nude
(Small round cell sarcoma PDX) 334 nude
(Spindle cell sarcoma PDX) 334 nude
(Synovial sarcoma PDX) 334 nude
Skin
(HPV16)BC-1-Ep/SL-LF 314 beige-nude-xid, nude, shrn®
Skin (benign)
Shope papilloma 301 nude
Squamous-cell/epidermoid carcinoma
A431 143, 211, 262, 264, 265, 266, 267, 268 nod.scid, nude, scid-beige
Testicular
NCCIT 53 nude
Uveal melanoma
M619 102 scid
MUM2B 102 scid
OCM1a 102 scid
Vulva
A431 327, 345 balb/c nude, nod.scid
SK-LMS-1 145 nude

Many factors can influence your selection of an appropriate research model. These published studies are identified to assist you in your selection. Envigo does not guarantee model performance in research studies.

The cell line abbreviation “(PDX)” is utilized as a generic naming convention of a “Patient-derived Xenograft” in absence of a formal name by the researcher(s).

  1. Verhoef, J.J.C. et al., Radiat Oncol, 2, 38 (2007). Netherlands (athymic nude mice )
  2. Ponthan, F. et al., Oncol Reports, 10, 1587 (2003). Netherlands (athymic nude rats)
  3. Rubenstein, J.L. et al., Neoplasia, 2(4), 306 (2000). North America (athymic nude rats)
  4. Plunkett, R.J. et al., J Neurosurg, 90, 1071 (1999). North America (athymic nude rats)
  5. Brignole, C. et al., J Natl Cancer Inst, 96, 1171 (2004). Italy (athymic nude mice, SCID-beige mice)
  6. Pan, Y. et al., Breast Cancer Res, 8, R63 (2006). North America (athymic nude mice)
  7. Sartorius, C.A. et al., Cancer Res, 65(21), 9779 (2005). North America (athymic nude mice)
  8. Arteaga, C.L. et al., Cell Growth & Diff, 4, 193 (1993). North America (athymic nude mice)
  9. Hardman, E.W. et al., Cancer Cell Intl, 2, 10 (2002). North America (athymic nude mice)
  10. Amiekhosravi, A. et al., Thromb Haemost, 90, 549 (2003). North America (athymic nude mice)
  11. Dikmen, Z.G. et al., Turk J Med Sci, 35, 65 (2005). North America (athymic nude mice )
  12. Richert, M.M. et al., Breast Cancer Res, 7, R819 (2005). North America (athymic nude mice)
  13. Burch, S. et al., J Biomedical Optics, 10, 034011-1-13 (2005). North America (athymic nude rats)
  14. Blask, D.E. et al., Breast Cancer Res, And Treatment 79, 313 (2003). North America (athymic nude rats)
  15. Bäuerle, T. et al., Intl J Oncol, 28, 573 (2006). Germany (athymic nude rats)
  16. Prewett, M.C. et al., Clin Cancer Res, 8, 994 (2002). North America (athymic nude mice)
  17. Sheng, H. et al., J Clin Invest, 99, 2254 (1997). North America (athymic nude mice )
  18. Yang, M. et al., Proc Nat Acad Sci, 102, 6027 (2005). North America (athymic nude mice )
  19. Park, B.H. et al., Proc Natl Acad Sci, 98, 2598 (2001). North America (athymic nude mice )
  20. Kruskal, J.B. et al., Radiology, 215, 852 (2000). North America (athymic nude mice)
  21. Tijink, B.M. et al., J Nucl Med, 47, 1127 (2006). EU (athymic nude mice)
  22. Marchal, F. et al., Oncology Reports, 14, 1203 (2005). France (athymic nude rats)
  23. Wang, M. et al., World J Gastroenterol, 9(11), 2627 (2003). France (athymic nude rats)
  24. Dauchy, R. T. et al., Cancer Letters, 209, 7 (2004). North America (athymic nude rats)
  25. Svechnikova, I. et al., Intl J Oncol, 22, 579 (2003). Netherlands (athymic nude rats)
  26. Till, H. et al., Surgical Endoscopy, 19, 1483 (2005). Germany (athymic nude rats)
  27. Barone, T.A. et al., Blood, 90, 298 (1997). North America (athymic nude rats)
  28. Francisco, J.A. et al., Blood, 102, 1458 (2003). North America (SCID mice)
  29. Geldhof, A.B. et al., Clin & Experimental Metastasis, 16(5), 447 (1998). North America (ICR-SCID mice)
  30. Wang, M. et al., Blood, 109, 5455 (2007). North America (SCID mice)
  31. Zou, Y. et al., J Natl Cancer Inst, 90, 1130 (1998). North America (athymic nude mice)
  32. Maneckjee, R. and Minna, J.D., Proc Natl Acad Sci, 89, 1169 (1992). North America (athymic nude mice)
  33. Weinberg, O.K. et al., Cancer Res, 65, 11287 (2005). North America (athymic nude mice)
  34. Boehle, A.S. et al., Intl J Cancer, 94, 420 (2001). Germany (SCID-beige mice)
  35. Horton, H.M. et al., Proc Natl Acad Sci, 96, 1553 (1999). North America (athymic nude mice, beige-nude-xid mice)
  36. Malafa, M.P. et al., Annals of Surgical Oncol, 9(10), 1023 (2002). North America (athymic nude mice)
  37. Bromberg, M.E. et al., Proc Natl Acad Sci, USA 92, 8205 (1995). North America (SCID mice)
  38. Modesitt, S.C. et al., Clin Cancer Res, 7,1487 (2001). North America (athymic nude mice)
  39. Duyndam, M.C.A. et al., Am J Pathol, 160, 537 (2002). Netherlands (athymic nude mice)
  40. Gossmann, A. et al., J Obstetrics and Gynecol, 183, 956 (2000). North America (athymic nude rats)
  41. Mahasreshti, P.J. et al., Clin Cancer Res, 7, 2057 (2001). North America (SCID mice)
  42. Fukasawa, M. and Murray, K., Clin Cancer Res, 10, 3327 (2004). North America (athymic nude mice)
  43. Koehler, J.A. and Drucker, D.J., Diabetes, 55, 1369 (2006). North America (athymic nude mice)
  44. Weber, D. et al., Cancer Res, 60, 5284 (2000). North America (athymic nude mice)
  45. Boenicke, L. et al., J Mol Med, 81, 205 (2003). Germany (SCID mice)
  46. Zhang, X. et al., J Nucl Med, 47, 492 (2006). North America (athymic nude mice)
  47. Tuomela, J.M. et al., BMC Cancer, 8, 81 (2008). Germany (athymic nude mice)
  48. Srivastava, S.K. et al., Carcinogenesis, 24(10), 1665 (2003). North America (athymic nude mice)
  49. Hillman, G.G. et al., Mol Cancer Ther, 3, 1271 (2004). North America (athymic nude mice)
  50. Graff, J.R. et al., J Biol Chem, 275, 24500 (2000). North America (athymic nude mice)
  51. Gregory, C.W. et al., Cancer Res, 61, 2892 (2001). North America (athymic nude mice)
  52. Cabrera, G. et al., Mol Cancer, 5, 32 doi:10.1186/1476-4598-5-32 (2006). North America (athymic nude rats)
  53. Adkins, H.B. et al., J Clin Invest, 112, 575 (2003). North America (athymic nude mice)
  54. Weydert, C. et al., Mol Cancer Ther, 2, 361 (2003). North America (athymic nude mice)
  55. Fu, X, Tao, L and Zhang, X., Cancer Gene Therapy, 14, 480 (2007). North America (athymic nude mice)
  56. Sun, L. and Chen, C., J Biol Chem, 272(40), 25367 (1997). North America (athymic nude mice)
  57. Sutherland, M.K. et al., mAbs 1(5), 481 (2009). North America (SCID mice)
  58. Lai, C.P.K. et al., Cancer Res, 67(4), 1545 (2007). North America (athymic nude mice)
  59. Folkins, C. et al., Cancer Res, 69(18), 7243 (2009). North America (athymic nude mice)
  60. Ueno, N.T. et al., Cancer Res, 62, 6712 (2002). North America (athymic nude mice)
  61. agata, Y. et al., Cancer Cell, 6, 117 (2004). North America (athymic nude mice )
  62. Puig, T. et al., Clin. Cancer Res., 15, 7608 (2009). UK (BALB/c nude mice )
  63. Liu, Z. et al., Nano Res, 3(3), 222 (2010). North America (athymic nude mice)
  64. Chandarlapaty, S. et al., Oncogene, 29, 325 (2010). EU (athymic nude mice)
  65. Simons, A.L. et al., Int J Radiat Oncol Biol Phys, 69(4), 1222 (2007). North America (athymic nude mice)
  66. Want, D. et al., Clin Cancer Res, 14(19), 6228 (2008). North America (athymic nude mice)
  67. LoTempio, M.M. et al., Clin Cancer Res, 11(19), 6994 (2005). North America (athymic nude mice)
  68. Barok, M. et al., Mol Cancer Ther, 6(7), 2065 (2007). Netherlands (NMRI nude mice, SCID mice)
  69. Tanner, M. et al., Mol Cancer Ther, 3(12), 1585 (2004). Netherlands (NMRI nude mice)
  70. Tanner, M. et al., Annals of Oncol, 16, 273 (2005). Netherlands (NMRI nude mice)
  71. Lin, L. et al., Neoplasia, 12(1), 39 (2010). North America (athymic nude mice)
  72. Moulder, S.L. et al., Cancer Res, 61, 8887 (2001). North America (athymic nude mice)
  73. Zhang, X. et al., Clin Cancer Res, 11, 323 (2005). North America (athymic nude mice)
  74. Campbell, R.A. et al., Int J Oncol, 28(6), 1409 (2006). North America (athymic nude mice)
  75. Chen, H. et al., Blood, 113, 1992 (2009). North America (athymic nude mice)
  76. Dingli, D. et al., Clin Cancer Res, 8, 3948 (2002). North America (SCID mice)
  77. Chavez-Blanco, A. et al., Cancer Cell Int, 6, 2 (2006). North America (athymic nude mice)
  78. Ferretti, S. et al., Neoplasia, 11(9), 874 (2009). EU (athymic nude mice)
  79. Heikkilä, J.E. et al., PLoS ONE, 5(1), e8603 (2010). UK (BALB/c nude mice)
  80. Xiao, W. et al., Eur J Nucl Med Mol Imaging, 36, 94 (2009). North America (athymic nude mice)
  81. Li, L. et al., Clin Cancer Res, 13(7), 2178 (2007). North America (athymic nude mice)
  82. Hsu, A.R. et al., J Nucl Med, 48, 445 (2007). North America (athymic nude mice)
  83. Chen, X. et al., J Nucl Med, 45, 1776 (2004). North America (athymic nude mice)
  84. Menon, C. et al., Am J Physiol Heart Circ Physiol, 24, H317 (2003). North America (athymic nude mice)
  85. Ueno, T. et al., Mol Cancer Ther, 5(3), 732 (2006). North America (athymic nude rats)
  86. Goyeneche, A.A. et al., Clin Cancer Res, 13(11), 3370 (2007). North America (athymic nude mice)
  87. Li, D. et al., Oncogene, 21, 2805 (2002). North America (athymic nude mice)
  88. Boehle, A.S. et al., Ann Thorac Surg, 69, 1010 (2000). Germany (SCID-beige mice)
  89. Kurdow, R. et al., Ann Thorac Surg, 73, 905 (2002). Germany (SCID-beige mice)
  90. Hamblett, K.J. et al., Clin Cancer Res, 10, 7063 (2004). North America (SCID mice)
  91. Santin, A.D. et al., Cancer Res, 65(10), 4334 (2005). North America (SCID mice)
  92. Nilsson, M.B. et al., J Biol Chem, 282(41), 29919 (2007). North America (SCID mice)
  93. Spaeth, E.L. et al., PloS ONE, 4(4), e4992 (2009). North America (SCID mice)
  94. Bruckheimer, E.M. et al., Neoplasia, 11(6), 509 (2009). North America (SCID mice, NOD.SCID mice)
  95. Nagengast, W.B. et al., J Nucl Med, 48, 1313 (2007). Netherlands (athymic nude mice)
  96. Auzenne, E. et al., Neoplasia, 9(6), 479 (2007). North America (athymic nude mice)
  97. Rodrigues-Ferreira, S. et al., PLoS ONE, 4(10), e7239 (2009). UK (SCID mice)
  98. Houba, P.H.J. et al., British J Cancer, 78(12), 1600 (1998). Netherlands (athymic nude mice)
  99. Vingerhoeds, M.H. et al., British J Cancer, 74, 1023 (1996). Netherlands (NMRI nude mice)
  100. Le Pimpec-Barthes, F. et al., British J Cancer, 81(8), 1344 (1999). EU (athymic nude rats)
  101. Fu, X. et al., Mol Ther, 7(6), 748 (2003). North America (athymic nude mice)
  102. Folberg, R. et al., Invest Ophthalmol Vis Sci, 48(7), 2967 (2007). North America (SCID mice)
  103. Swami S., et.al., Horm Cancer. 2011 June 1; 2(3): 190-202. North America (athymic nude mice)
  104. Kiyama, S. et al., Cancer Res, 63, 3575 (2003). North America (athymic nude mice)
  105. Elsadek, B. et al., Prostate Cancer and Prostatic Diseases, 14, 14 (2011). Germany (SCID mice)
  106. Sun, S. et al., J Clin Invest, 120(8), 2715 (2010). North America (athymic nude mice)
  107. Li, T.H. et al., Nucleic Acids Res, 35(8), 2767 (2007). North America (athymic nude mice)
  108. Pan, J. et al., PLoS ONE, 5(10), e13298. doi:10.1371/journal.pone.0013298 (2010). North America (athymic nude mice)
  109. Määttä, A.-M. et al., Int J Cancer, 121, 863 (2007). Netherlands (NMRI nude mice)
  110. Jarzynka, M.J. et al., Int J Oncol, 28(2), 337 (2006). North America (athymic nude mice)
  111. Bruckheimer, E.M. et al., Neoplasia, 11(6), 509 (2009). North America (athymic nude mice, SCID mice, NOD.SCID mice)
  112. Yi, J. M. et al., Cancer Res, 68(19), 8094 (2008). North America (SCID mice)
  113. Ovalle, S. et al., Int J Cancer, 121, 2140 (2007). Spain (athymic nude mice )
  114. Schleup, T. et al., Clin Cancer Res, 15, 181 (2009). North America (athymic nude mice )
  115. Orian-Rousseau, V. et al., Int J Cancer, 113, 699 (2005). Germany (SCID-beige mice)
  116. Zielske, S.P. et al., Int J Radiat Oncol Biol Phys, 75(3), 843 (2009). North America (athymic nude mice)
  117. Kaafarani, I. et al., FASEBJ, 23, doi: 10.1096/fj.08-127852 (2009). France (NMRI nude mice)
  118. Koskimaki, J. E. et al., BMC Cancer, 10, 29 (2010). North America (athymic nude mice)
  119. Jakubezak, J.L. et al., Cancer Res, 63, 1490 (2003). North America (athymic nude mice)
  120. McEarchern, J.A. et al., Clin Cancer Res, 14, 7763 (2008). North America (SCID mice)
  121. Kelley, S.K. et al., Br J Pharmacol, 148(8), 1116 (2006). North America (SCID mice)
  122. Smrekar, B. et al., Gene Therapy, 10, 1079 (2003). UK; Germany (SCID mice)
  123. Tremmel, M. et al., Blood, 114(25), 5236 (2009). Germany (athymic nude mice)
  124. Cuesta, Á.M., et al., PLoS ONE, 4(4), e5381. doi:10.1371/journal.pone.0005381 (2009). Spain (athymic nude mice)
  125. Pastorino, F. et al., Cancer Res, 63, 86 (2003). Italy (athymic nude mice )
  126. Kelly, P. et al., British J Cancer, 103, 232 (2010). UK (SCID mice)
  127. Larkin, J.O. et al., Ultrasound Med Biol, 34(3), 406 (2008). UK (MF1 nude mice)
  128. Kang, K.S., et al., PLoS ONE 5(4): e10296. doi:10.1371/journal.pone.0010296 (2010). North America (athymic nude mice)
  129. Shah, G.V. et al., Endocrine-Related Cancer, 15, 953 (2008). North America (athymic nude mice)
  130. Lipnik, K. et al., Virol, 349, 121 (2006). Germany (SCID-beige mice)
  131. Agu, C.A. et al., J Gene Med, 8, 229 (2006). Germany (SCID-beige mice)
  132. Rhodes, L.V. et al., Breast Cancer Res Treat, 121(2), 293 (2010). North America (SCID-beige mice)
  133. Barone, T.A. et al., J Neuro-Oncol, 95(1), 37 (2009). North America (athymic nude rats)
  134. Nanda, D. et al., Cancer Res, 61, 8743 (2001). UK (beige-nude-xid mice)
  135. Markaverich, B. et al., Eviron Health Perspect,110, 169 (2002). North America (athymic nude mice)
  136. Stan, S.D. et al., Cancer Res, 68(18), 7661 (2008). North America (athymic nude mice)
  137. Shashkova, E.V. et al., Cancer Res, 68, 5896 (2008). North America (athymic nude mice)
  138. Larkin, J.O. et al., Ann Surg, 245(3), 469 (2007). UK (BALB/c nude mice, MF1 nude mice)
  139. Loebinger, M.R. et al., Cancer Res, 69(23), 8862 (2009). UK (NOD.SCID mice)
  140. Cai, W. et al., J Nucl Med, 48, 304 (2007). North America (athymic nude mice)
  141. Squires, M.S. et al., Mol Cancer, 8(2), 324 (2009). UK (BALB/c nude mice)
  142. Airoldi, I. et al., PLoS ONE, 4(7), e6119. doi:10.1371/journal.pone.0006119 (2009). Italy (NOD.SCID mice)
  143. Lee, F.Y.F. et al., Cancer Chemother Pharmacol, 63, 201 (2009). North America (athymic nude mice, SCID-beige mice)
  144. Yang, J. et al., Cancer Cell, 10, 295 (2006). North America (SCID mice)
  145. Dauchy, R.T. et al., J Pineal Res, 47, 32 (2009). North America (athymic nude rat)
  146. Wu, J. et al., Cancer Res, 71, 2622 (2011). North America (athymic nude rat)
  147. Sharma, S. et al., Ejc Supplements, ISSN:13596349, 8(7), 66 (2010). North America (athymic nude mice)
  148. Hadaschik, B.A. et al., Cancer Res, 68, 4506 (2008). North America (athymic nude mice)
  149. Chadalapaka, G. et al., Cancer Res, 68(13), 5345 (2008). North America (athymic nude mice)
  150. Cho, S.D. et al., Mol Pharmacol, 77(3), 396 (2010). North America (athymic nude mice)
  151. Jutooru, I. et al., Exp Cell Res, 316(13), 2174 (2010). North America (athymic nude mice)
  152. Zawel, L. et al., PNAS, 99(5), 2848 (2002). North America (athymic nude mice)
  153. Donawho, C.K. et al., Clin Cancer Res, 13(9), 2728 (2007). North America (athymic nude mice)
  154. Rockett, J.C. et al., Br J Cancer, 75(2), 258 (1997). UK (athymic nude mice)
  155. Kan, T. et al., Gastroenterol, 136(5), 1689 (2009) North America (athymic nude mice)
  156. Zhang, S. et al. Mol Cancer Ther, 11, 108 (2012). North America (athymic nude mice)
  157. Zhang, K.-X. et al., Breast Cancer Res Treat, 125, 89 (2011). North America (athymic nude mice)
  158. Zhang, K.-X. et al., Breast Cancer Res Treat, 125, 89 (2011). North America (athymic nude mice)
  159. Liu, Z. et al., Nano Res, 3, 222 (2010). North America (athymic nude mice)
  160. Rimawi, M.R. et al., Clin Cancer Res, 17, 1351 (2011). North America (athymic nude mice)
  161. Zhao, Y. et al., Cancer Res, 71, 4585 (2011). North America (athymic nude mice)
  162. Scaltriti, M. et al., Mol Cancer Ther, 10, 817 (2011). North America (athymic nude mice)
  163. Massey, A.J. et al., Mol Cancer Ther, 9, 906 (2010). Switzerland (athymic nude mice)
  164. Maira, S.-M. et al., Mol Cancer Ther, doi:10.1158/1535-7163.MCT-11-0474. Switzerland (athymic nude mice)
  165. O'Donovan, N. et al., Invest New Drugs, 29, 752 (2011). UK (BALB/c nude mice)
  166. Chao, O. et al., J Med Chem, 52, 7808 (2009). North America (athymic nude mice)
  167. Yu, Y.A. et al., Mol Cancer Ther, 8, 141 (2009). North America (athymic nude mice)
  168. Haddad, D. et al., J Translational Med, 9, 36 (2011). North America (athymic nude mice)
  169. Gourdeau, H. et al., Cancer Chemother Pharmacol, 61, 911 (2008). North America (athymic nude mice)
  170. Liu, T.W. et al., Bioconjugate Chem, 22, 1021 (2011). North America (athymic nude mice, athymic nude rats)
  171. Alzani, R. et al., Exp Hematol, 38, 259 (2010). Italy (SCID mice)
  172. Sehdev, V. et al., Mol Cancer Ther, doi: 10.1158/1535-7163.MCT-11-0623 (2012). North America (athymic nude mice)
  173. Bralten, L.B.C. et al., Ann Neurol, 69, 455 (2011). Netherlands (SCID mice)
  174. Ayuzawa, R. et al., Cancer Letters,280, 31 (2009). North America (SCID mice)
  175. Barok, M. et al., Cancer Letters, 306, 171 (2011). Netherlands (SCID mice)
  176. Zeng, Q. et al., Euro J Cancer, 46, 1132 (2010). North America (athymic nude mice)
  177. Pais, A. et al. Cancer Res, 71(24), 7387 (2011). Israel (SCID mice)
  178. Junttila, T.T. et al., Cancer Cell, 15, 429 (2009). North America (SCID mice)
  179. Daigle, S. R. et al., Cancer Cell, 20, 53 (2011). North America (athymic nude mice)
  180. Patyna, S. et al. Mol Cancer Ther, 5, 1774 (2006). North America (athymic nude mice, NOD.SCID mice)
  181. Zarrinkar, P.P. et al. Blood, 114(14), 2984 (2009). North America (NOD.SCID mice)
  182. Mertz, J.A. et al., PNAS, 108(40), 16669 (2011). North America (athymic nude mice)
  183. Tokalov, S.V. et al., J Biomed and Biotechnol, Article ID 580531, 4 p doi:10.1155/2010/580531 (2010). Germany (athymic nude rats)
  184. Anastas, J.N. et al., Oncogene, doi:10.1038/onc.2011.528 (2011). North America (athymic nude mice)
  185. Mitra, A. et al., Breast Cancer Res, 10:R22 (2008). North America (athymic nude mice)
  186. Volk, L.D. et al., Neoplasia, 10(6), 613 (2008). North America (athymic nude mice)
  187. Hiraga, T. et al., Cancer Res, 61, 4418 (2001). North America (athymic nude mice)
  188. Mukhopadhyay, K.D. et al., PLoS ONE, 6(6), e20473 (2011). North America (athymic nude mice)
  189. Bandyopadhyay, A. et al., PLoS ONE, 5(4), e10365 (2010). North America (athymic nude mice)
  190. Walsh, C. et al., Cancer Biol Ther, 9(10), 778 (2010). North America (athymic nude mice, BALB/c SCID mice)
  191. Lee, S.-M. et al., ACS Nano, 4(9), 4971 (2010). North America (athymic nude mice)
  192. Kerjaschki, D. et al. J Clin Invest, 121(5), 2000 (2011). Germany (SCID mice)
  193. Whitehurst, B. et al., Int J Cancer, 121, 2181 (2007). North America (SCID mice)
  194. Graeser, R. et al., Int J Cancer, 122, 1145 (2008). Germany (SCID mice)
  195. Gomez-Manzano, C. et al., Neuro-Oncol, 10, 940 (2008). North America (athymic nude mice)
  196. et al., Cancer Gene Ther, 12, 947 (2005). Germany (athymic nude mice)
  197. Verheije, M.H. et al., J Virol, 83(15), 7507 (2009). Netherlands (athymic nude mice)
  198. Ke, L.D. et al., Clin Cancer Res, 6, 2562 (2000). North America (athymic nude mice)
  199. Clark, A.J. et al., J Neurosurg, 112, 18 (2010). North America (athymic nude mice)
  200. Calzolari, A. et al., Transl Oncol, 3(2), 123 (2010). Italy (athymic nude mice)
  201. Schiappacassi, M. et al., Mol Cancer Ther, 7(5), 1164 (2008). Italy (athymic nude mice)
  202. Yoon, H. et al., J Cellular Biochem, 108, 832 (2009). North America (athymic nude mice)
  203. Abourbeh, G. et al., Nucl Med and Biol, 34, 55 (2007). Israel (athymic nude mice)
  204. Benny, O. et al., FASEB J, 22, 488 (2008). Israel (CD-1 nude mice)
  205. Yin, S. et al., Neuro-Oncol, 12(1), 19 (2010). Sweden (athymic nude rats)
  206. Khan, Z. et al., Neuro-Oncol, 12(6), 549 Sweden (athymic nude rats)
  207. Buursma, A.R. et al., J Nucl Med, 46, 2068 (2005). Netherlands (athymic nude rats)
  208. Gunasekaran, K. et al., J Biol Chem, 285(25), 19637 (2010). North America (NOD.SCID mice)
  209. Li, J.-L. et al., Cancer Res, 67(23), 11244 (2007). Germany (BALB/c SCID mice)
  210. Holen I., et.al., Breast Cancer Research 2012, 14:R86. United Kingdom (BALB/c nude mice)
  211. Hennessy, B.T. et al. Clin Cancer Res, 13(24), 7421 (2007). North America (athymic nude mice)
  212. Nakamori, M. et al., 9, 2727 (2003). North America (athymic nude mice)
  213. Ma, L. et al., Acta Biochim Biophys Sin, 42(9), 593 (2010). Asia (BALB/c nude mice)
  214. Shao, M. et al., Cancer Res, 69, 9192 (2009). North America (BALB/c nude mice)
  215. Lljin, K. et al., Clin Cancer Res, 15(19), 6070 (2009). Finland (athymic nude mice)
  216. Izhak, L. et al., J Immunol, 183, 732 (2009). Israel (SCID-beige mice)
  217. Inbar-Rozensal, D. et al., Breast Cancer Res, 11, R78 (2009). Israel (CD-1 nude mice)
  218. González, L. et al., J Biol Chem, 281(30), 20851 (2006). Spain (athymic nude mice)
  219. Wu, L. et al., Clin Cancer Res, 11(22), 8195 (2005). North America (athymic nude mice)
  220. Ghosh, A.K. et al., Cancer Res, 56(3), 718 (2005). North America (athymic nude mice)
  221. Tang, L. et al., J Nutr, 135, 287 (2005). North America (athymic nude mice)
  222. Fu, X. et al., Gene Ther, 10, 1458 (2003). North America (athymic nude mice)
  223. Shashkova, E.V. et al., Cancer Res, 68(14), 5896 (2008). North America (athymic nude mice)
  224. Ozawa, T. et al., Mol Pharmaceutics, 1(5), 368 (2004). North America (athymic nude rats)
  225. Bristol, J.A. et al., Mol Ther, 7(6), 755 (2003). North America (athymic nude mice)
  226. Folgiero, V. et al., Cell Death and Disease, 3, e440; doi:10.1038/cddis.2012.179 (2012). Italy (athymic nude mice, SCID mice)
  227. Jensen, M.R. et al., Breast Cancer Res, 10, R33 (2008). Switzerland (athymic nude mice)
  228. Golubovskaya, V.M. et al., J Med Chem, 51(23), 7405 (2008). North America (athymic nude mice)
  229. Hernandez-Alcoceba, R. et al., Human Gene Ther, 11, 2009 (2000). North America (athymic nude mice)
  230. Gutierrez, M.C. et al., JCO, 23(11), 2469 (2005). UK (athymic nude mice)
  231. Mahller, Y.Y. et al. PLoS ONE, 4(1):e4235. doi:10.1371/journal.pone.0004235 (2009). North America (athymic nude mice)
  232. Zhou, Y. et al., J Biol Chem, 286, 32843 (2011). North America (athymic nude mice)
  233. Salvatori, L. et al., PLoS ONE, 7(2), e31467. doi:10.1371/journal.pone.0031467 (2012). Italy (NOD.SCID mice)
  234. Londoño-Joshi, A.I. et al., Breast Cancer Res Treat, DOI 10.1007/s10549-011-1763-0 (2011). North America (NOD.SCID mice)
  235. Joseph, I. et al., Cancer Res, 70, 9494 (2010). North America (athymic nude mice)
  236. Lonardo, E. et al., Cell Stem Cell, 9(5), 433 (2011). Spain (athymic nude mice)
  237. Xiao, K. et al., Biomaterials, 30(30), 6006 (2009). North America (athymic nude mice)
  238. Li, Y. et al., J Immunol, 179, 4263 (2007). North America (SCID mice)
  239. Kumagai, T. et al., J Natl Cancer Inst, 95(12), 896 (2003). North America (beige-nude-xid mice)
  240. Kumagai, T. et al., Clin Cancer Res, 10, 1508 (2004). North America (beige-nude-xid mice)
  241. Audo, I. et al., Invest Ophthalmol Vis Sci, 44, 4192 (2003). North America (athymic nude mice)
  242. Cocco, C. et al., Clin Cancer Res, 16, 4188 (2010). Italy (NOD.SCID mice)
  243. Ayers, G.D. et al., J Ultrasound Med, 29(6), 891 (2010). North America (athymic nude mice)
  244. Ning, S. et al., Cancer Res, 70(19), OF1 (2010). North America (athymic nude rats)
  245. Yee, A.J.M. et al., Breast Cancer Res, 9(4), R47 (2007). North America (CD-1 nude mice, athymic nude rats )
  246. Mercatelli, N. et al., PLoS ONE, 3(12), e4029 (2008). Italy (SCID mice)
  247. Thallinger, C. et al., J Invest Dermatol, 127, 2411 (2007). Germany (SCID mice)
  248. Elsner, L. et al., J Immunol, 179, 5523 (2007). Germany (SCID-beige mice)
  249. Ren, G. et al., J Nucl Med, 50, 1692 (2009). North America (athymic nude mice)
  250. Morello, S. et al., Neoplasia, 13(4), 365 (2011). Italy (athymic nude mice)
  251. Stangl, S. et al., J Immunol, 176, 6270 (2006). Germany (SCID-beige mice)
  252. Phillips, G.D.L. et al., Cancer Res, 68, 9280 (2008). North America (beige-nude-xid mice)
  253. Lee-Hoeflich, S.T. et al., Cancer Res, 68, 5878 (2008). North America (beige-nude-xid mice)
  254. Yao, E. et al., Clin Cancer Res, 15, 4147 (2009). North America (beige-nude-xid mice)
  255. Allegrucci, C. et al., Mol Cancer, 10, 7 (2011). UK (MF1 nude mice)
  256. Brachmann, S.M. et al., PNAS, 106(52), 22299 (2009). North America (athymic nude mice)
  257. Hoeflich, K.P. et al., Clin Cancer Res, 15(14), 4649 (2009). North America (beige-nude-xid mice)
  258. Wong, T.W. et al., Clin Cancer Res, 12(20), 6186 (2006). North America (athymic nude mice)
  259. Halasi, M. et al., Cell Cycle, 9(4), 1214 (2010). North America (athymic nude mice)
  260. Zhang, S. et al., Endocrine-Related Cancer, 16, 835 (2009). North America (athymic nude mice)
  261. Hitosugi, T. et al., Mol Cell, 44(6), 864 (2011). North America (athymic nude mice)
  262. Jimeno, A. et al., Cancer Res, 65, 3003 (2005). North America (athymic nude mice)
  263. Mutsaers, A.J. et al., Clin Cancer Res, 15, 2397 (2009). North America (athymic nude mice)
  264. Guix, M. et al., J Clin Invest, 118(7), 2609 (2008). North America (athymic nude mice)
  265. Donnini, S. et al., Oncogene, doi:10.1038/onc.2011.503 (2011). Italy (athymic nude mice)
  266. Shir, A. et al., Clin Cancer Res, 17, 1033 (2011). Israel (NOD.SCID mice)
  267. Lee, C.M. et al., BMC Cancer, 10, 255 (2010). North America (athymic nude mice)
  268. Alameda, J.P. et al., Cell Death and Disease, 2, e208; doi:10.1038/cddis.2011.82 (2011). Spain (athymic nude mice)
  269. Valle BL, et al,. PLoS ONE 8(4): e61836 (2013). North America (athymic nude mice)
  270. Zhang C.C, et.al., Clinical Cancer Research 1-12; 2012. AACR. France (athymic nude mice)
  271. Carlson B. L, et.al., Curr Protoc Pharmocol. 2011 mar; Chapter 14: Unit 14. 16 (2011). North America (athymic nude mice)
  272. Calles A., et.al., Curr Protoc Pharmacol. 2013 Jun; Chapter 14: Unit 14.26 (2013). North America (NOD.SCID mice, athymic nude mice)
  273. Litzenburger BC., et.al., Clin Cancer Res April 15, 2011. 17; 2314. North America (NOD.SCID mice)
  274. Schott AF, et.al., Clin Cancer Res clincanres.3326.2012; Published Online First January 22, 2013. North America (SCID-beige mice)
  275. Leake K, et.al., PLoS ONE 7(4): e34582 (2012). North America (athymic nude mice)
  276. Zhao S, et.al., Oncogenesis (2013) 2, e76. North America (athymic nude mice)
  277. Hernandez JL, et.al., PLoS ONE 8(9): e72480 (2013). Spain (athymic nude mice)
  278. Jager W, el.al., PLoS ONE 8(3): e59536 (2013). North America (athymic nude mice)
  279. Shin D.H, et.al., JNCI J Natl Cancer Inst (2013). North America (athymic nude mice)
  280. Venkatasubbarao K, et.al., Molecular Cancer 2013, 12:104. North America (athymic nude mice)
  281. Rybczynska A.A, el.al., J Nucl Med September 1, 2013. The Netherlands (athymic nude mice)
  282. Gholami S, et.al., Breast Cancer Research 2013, 15:R26. North America (athymic nude mice)
  283. Zins K, et.al., Mol. Sci. 2013, 14, 17958-17971. Germany (athymic nude mice)
  284. Benavente S, et.al., Clin Cancer Res March 1, 2009 15; 1585. North America (athymic nude mice)
  285. Verhoeff JJC, et.al., Radiation Oncology 2007, 2:38. The Netherlands (athymic nude mice)
  286. Alessandro GD, et.al., Cell Death and Disease (2013) 4, e773. Italy (C.B-17 SCID mice)
  287. Jiang J., et.al., Oncol Rep. 2012 October; 28(4): 1139-1145. North America (athymic nude mice)
  288. Koht HE., et.al., The Journal of Clinical investigation. Volume 122, number 3, March 2012. North America (athymic nude mice)
  289. Barok M., et.al., Breast Cancer Research 2011, 13:R46. The Netherlands (C.B-17 SCID mice)
  290. Thorner Ar., et.al., PLoS ONE 5(10)e13073. North America (athymic nude mice)
  291. Hamada K., et.al., Gynecologic Oncology 99 (2005) S159-S165. North America (athymic nude rats)
  292. Lheureux S., et.al. Transl Oncol. 2013 October; 6(5): 586-595. North America (athymic nude rats)
  293. Millar HJ., et.al., Cancer Epidemiol Biomarkers Prev August 2008 17; 2180. North America (athymic nude rats)
  294. Ayers GD., et.al., JUM June 1, 2010 vol. 29 no. 6 891-90. North America (athymic nude mice)
  295. Cyran CC., et.al., PLoS ONE 8(9): e76009. North America (athymic nude rats)
  296. Daigle SR., et.al., Blood 2013 122: 1017-1025. North America (athymic nude rats)
  297. Jafri SH., et al., Journal of Experimental & Clinical Cancer Research 2010 29:87. North America (C.B-17 SCID mice)
  298. Dingli D., et al., Blood 2003 102: 489-496. North America (C.B-17 SCID mice)
  299. Green TP., et.al., Molecular Oncology 3 (2009), 248-261. France (athymic nude mice)
  300. Kreider JW., at al., Cancer Research 39, 273-276, January 1979. North America (athymic nude mice)
  301. Welsch CW, et.al, JNCI J Natl Cancer Inst (1987) 78 (3): 557-565. North America (athymic nude mice)
  302. Park SI., et.al., Curr Protoc Pharmacol. 2010 December 1; 51: 14.15-14.15.27. North America (athymic nude mice)
  303. Fernandes MS., et.al., Clin Cancer Res August 1, 2009 15; 4847. North America (C.B-17 SCID mice)
  304. Mundra JJ., et.al, JPET August 2012 vol. 342 no. 2 273-287. North America (SCID mice)
  305. Peng KW., et.al., Blood, 1 October 2001. Vol. 98. Numb. 7. North America (C.B-17 SCID mice)
  306. Bhatia N., et.al., J Invest Dermatol. 2013 March ; 133(3): 759-767. North America (athymic nude mice)
  307. Mischek D., et.al., Journal of Biomedicine and Biotechnology, Volume 2009 (2009), Article ID 437284. Germany (SCID-beige mice)
  308. Harrell JC., et.al., Cancer Res September 15, 2006 66; 9308. North America (athymic nude mice)
  309. Kumar S., et.al., Am J Pathol. 2003 December; 163(6): 2531-2541. North America (athymic nude mice)
  310. Schafer JM., et.al., Clin Cancer Res November 2000 6; 4373. North America (athymic nude mice)
  311. Gottardis MM., et.al., J Steroid Biochem. 1988;30(1-6):311-4. North America (athymic nude mice)
  312. O’Regan RM., et. al., JNCI J Natl Cancer Inst (2002) 94 (4): 274-283. North America (athymic nude mice)
  313. Morrison MM., J Clin Invest. 2013;123(10):4329-4343. North America (athymic nude mice)
  314. Suhong Xiao, et.al., The Journal of Biological Chemistry, 287, 12559-12577. North America (athymic nude mice, beige-nude-xid mice, SHrN® mice)
  315. Nguyen N, et.al., Cancer Prev Res. February 2011 4; 248. North America (athymic nude mice)
  316. Wang S, at.al., Cancer Gene Therapy (2002) 9, 1-8. doi:10.1038/sj.cgt.7700402. North America (athymic nude mice)
  317. Mathieu V.et.al, Oncotarget. Apr 2012; 3(4): 399-413. Germany (BALB/c SCID mice)
  318. Vaha-Koskela MJV., et.al., Cancer Res July 15, 2006 66; 7185. The Netherlands (SCID mice)
  319. Thallinger C., et.al., Journal of Investigative Dermatology (2003) 120, 1081-1086; doi:10.1046/j.1523-1747.2003.12252.x. Germany (C.B-17 SCID mice)
  320. Mathieu MG., et.al., Cell Death and Disease (2014) 5, e1061; doi:10.1038/cddis.2014.29 Published online 13 February 2014. United Kingdom (NOD.SCID mice)
  321. Hafner C., et.al., Int. J. Cancer: 114, 426-432 (2005). Germany (C.B-17 SCID mice)
  322. Luciani F, et.al., Oxford Journals Medicine JNCI J Natl Cancer Inst Volume 96, Issue 22 Pp. 1702-1713. Italy (C.B-17 SCID mice)
  323. Ong C.C., et.al., JNCI J Natl Cancer Inst (2013) djt054 doi: 10.1093/jnci/djt054. North America (beige-nude-xid mice)
  324. Lotan T., et.al., Cancer Res. Apr 1, 2008; 68(7): 2166-2175. North America (beige-nude-xid mice)
  325. Goel A., et.al., Blood 2007 110: 2342-2350. North America (beige-nude-xid mice)
  326. Zeng Y, et.al., J Biol Chem. Apr 22, 2011; 286(16): 13985-13994. North America (C.B-17 SCID mice)
  327. Hofmann M., et.al., Neoplasia (New York, N.Y.) (Impact Factor: 5.48). 09/2009; 11(8):812-22. Germany (NOD.SCID mice)
  328. Wang L., et.al., J Clin Neurosci. Jun 2012; 19 (6): 881-883. North America (NOD.SCID mice)
  329. Sharad S. Singhal, et.al., Cancer Res. May 15, 2009; 69(10): 4244-4251. North America (athymic nude mice)
  330. Amornphimoltham P., et.al., Clin Cancer Res. Mar 15, 2013; 19(6): 1375-1388. North America (athymic nude mice)
  331. Ricci-Vitiani L., et.al., Cell Death and Differentiation (2008) 15, 1491-1498; doi:10.1038/cdd.2008.72; published online 23 May 2008. Italy (athymic nude mice)
  332. Chiron M., et.al., Mol Cancer Ther June 2014 13; 1636. France (NMRI nude mice)
  333. Presnell SC., et.al., Am J Pathol. Sep 2001; 159(3): 855-860. North America (athymic nude mice)
  334. Stebbing J., et.al., Cancer. Volume 120, Issue 13, pages 2006-2015, 1 July 2014. North America (athymic nude mice)
  335. Weekes CD., et.al., Neoplasia. Aug 2012; 14(8): 69-701. North America (athymic nude mice)
  336. Pitts TM, et al., (2014) PLoS ONE 9(11): e113037. doi:10.1371/journal.pone.0113037. North America (athymic nude mice)
  337. Toussaint G.L., et.al., Molecular Cancer 2012, 11:32. North America (athymic nude mice)
  338. Bradshaw-Pierce E.L., et.al., Front. Pharmacol., 22 March 2013 | doi: 10.3389/fphar.2013.00022. North America (athymic nude mice)
  339. Petit V., et.al., Laboratory Investigation (2013) 93, 611-621; doi:10.1038/labinvest.2013.44; published online 4 March 2013. France (BALB/c nude mice)
  340. Anne L van de Ven, et.al., New Journal of Physics 15 (2013) 055004. North America (SCID-beige mice)
  341. Tchoghandjian A., et.al., Cell Death & Differentiation 21, 735-747 (May 2014). France (athymic nude mice)
  342. Veeravagu A., et.al., Clin Cancer Res November 15, 2008 14; 7330. North America (athymic nude mice)
  343. Mei J., et.al., Mol Cell Biol. Sep 2011; 31(7):3584-3592. North America (NOD.SCID mice)
  344. Wang J., et al., Cancer Cell 12, 239-251, September 2007. North America (athymic nude mice)
  345. Chisholm EJ., et.al., Cancer Res March 15, 2009 69; 2655. United Kingdom (BALB/c nude mice)
  346. Gao Z., et.al., International Journal of Cancer Volume 82, Issue 3, pages 346-352, 30 July 1999. North America (athymic nude mice)
  347. Dauchy RT., et.al., Comparative Medicine. Vol. 62, No 2, April 2012, pages 99 - 108. North America (athymic nude rats)
  348. Diagle SR., et.al., Blood: 122 (6). August 8, 2013. North America (athymic nude rats)
  349. Serra V, et.al., J Clin Invest. 2013;123(6):2551-2563. Spain (athymic nude mice, NMRI nude mice)
  350. Nephew KP., et. al., Cancer Res Published OnlineFirst July 17, 2014. North America (athymic nude mice)
  351. Pirazzoli V., et.al., Cell Reports 7, 999-1008, May 22, 2014. North America (athymic nude mice)
  352. Garcia R.R., et.al., Am J Clin Exp Urol 2014;2(1):82-91. North America (athymic nude mice)
  353. Nofiele JT., et.al., PLoS ONE 9(5): e97950. North America (athymic nude rats)
  354. Kolev, V.N., et al., Cancer Res January 15, 2015 75; 446. North America (SHrN™ mice, NOD.SCID mice)
  355. Colletti, JA II et al. G3 (Bethesda). 4 (2014) 1385-1394. North America (Brown Norway rats)
  356. Munson, JM., et al. Cancer Res. 73 (2013) 1536-1546. Swtizerland (Fisher 344 rats)
  357. Bhattacharya, A., et al. Carcinogenesis. 34 (2013) 2593-2599. North America (Fisher 344 rats)
  358. Janakiram, NB., et al., Cancer.Prev.Res.(Phila). 6 (2013) 1251-1261. North America (Fisher 344 rats)
  359. Ravillah, D., et al. et al., J.Pharmacol.Exp.Ther. 348 (2014) 59-68. North America (Fischer 344 rats)
  360. Shi, N., et al. Oncotarget. 5 (2014) 11333-11344. North America (Fischer 344 rats)
  361. Yang, L., et al., Int.J.Biochem.Mol.Biol. 3 (2012) 46-57. China (Fischer 344 rats)
  362. Stypula-Cyrus, Y., et al., FEBS Lett. 588 (2014) 829-835. North America (Fischer 344 rats)
  363. Khazal, KF., et al. Anticancer Res. 33 (2013) 1519-1523. North America (Spraque Dawley rats)
  364. Ouyang, N., et al. Int.J.Oncol. 42 (2013) 643-650. North America (Fischer 344 rats)
  365. Ostertang D., et.al., Neuro Oncol. 2012 February; 14(2): 145–159. North America (B6C3F1 mice)
  366. Rashid OM., et.al., Journal of Thoracic Disease. Vol 5, No 4 (August 2013). North America (BALB/c mice)
  367. Anz, D., et al, Int.J.Cancer 129 (2011) 2417-2426. Germany (C57BL/6 mice; BALB/c mice)
  368. Barbieri, A., et al, J.Cell.Mol.Med. 16 (2012) 920-926. Italy (C57BL/6 mice)
  369. Adinolfi, E., et al. Cancer Res. 72 (2012) 2957-2969. Italy (C57BL/6 mice; BALB/c mice)
  370. Gurzov, EN., et al. Oncogene 27 (2008) 641-652. Spain (C57BL/6 mice)
  371. Basile, LA., et al. J.Transl.Med. 6 (2008) 26-5876-6-26. North America (C57BL/6 mice)
  372. Balkow, S., et al, Exp.Dermatol. 18 (2009) 78-87. Germany (C57BL/6 mice)
  373. Llopiz, D., et al, Int.J.Cancer 125 (2009) 2614-2623. Spain (C57BL/6 mice)
  374. Jacobs, C., et al, Int.J.Cancer 128 (2011) 897-907. Germany (C57BL/6 mice)
  375. Aranda, F., et al, Cancer Res. 71 (2011) 3214-3224. 2011. Spain (C57BL/6 mice)
  376. Li, X., et al, Oncogene 27 (2008) 7118-7130. North America (C57BL/6 mice)
  377. Spitzer, D., et al, Cancer Res. 72 (2012) 201-209. North American (C57BL/6 mice)
  378. Uluckan, MC., et al, J.Cell.Biochem. 104 (2008) 1311-1323. North American (C57BL/6 mice)
  379. Bandyopadhyay, A., et al. PLoS One 5 (2010) e10365. North America (BALB/c mice)
  380. Cambien, B., et al, PLoS One 6 (2011) e28842. France (BALB/c mice)
  381. Cooney, CA., et al, Breast Cancer Res. 13 (2011) R58. North America (BALB/c mice)
  382. Israyelyan, A., et al. Virol.J. 5 (2008) 68-422X-5-68. North America (BALB/c mice)
  383. Jungwirth, U., et al. et al, Mol.Pharmacol. 81 (2012) 719-728. Austria (BALB/c mice)
  384. Lapteva, N., et al. J.Immunother. 32 (2009) 145-156. North America (BALB/c mice, C57BL/6J mice)
  385. Mojic, M., et al. Mol.Pharmacol. 82 (2012) 700-710. Serbia (BALB/c mice)
  386. Qiao, Y., et al. Oncotarget 2 (2011) 59-68. North America (BALB/c mice)
  387. Vanrell, L., et al, Mol.Ther. 19 (2011) 1245-1253. Spain (BALB/c mice)
  388. Vigneswaran, N. et al. Exp.Mol.Pathol. 90 (2011) 215-225. North America (BALB/c mice)
  389. Walsh, C., et al, Cancer.Biol.Ther. 9 (2010) 778-790. North America (BALB/c mice)
  390. Zhang, M., et al, Cancer Res. 68 (2008) 4674-4682. North America (BALB/c mice)
  391. Zigmond, E., et al. PLoS One 6 (2011) e28858. Israel (BALB/c mice)
  392. Ganesh, S., et al. Mol Cancer Ther (2016) Jul 7. North America (athymic nude mice)
  393. Jiménez-Valerio, G. et al. Cell Rep. (2016) May 10; 15(6):1134-43. Spain (athymic nude mice)
  394. Zhao, S., et al., Clin Cancer Res. (2016) Jun 7. North America (athymic nude mice)
  395. Francis, DM., et al. Clin Cancer Res. (2016) Feb 1; 22(3):633-43. North America (athymic nude mice)
  396. Crottès D., et al. Cancer Res. 2016 Feb 1; 76(3):607-18. France (SHrN™ mice)
  397. Kathagen-Buhmann A., et al. Neuro Oncol. 2016 Feb 24. Germany (SHrN™ mice)
  398. Jones R.J., et al. Clin Cancer Res. 2016 Jun 13. North America (C.B-17 SCID mice)
  399. Alagpulinsa D.A., et al. Mol Cancer Ther. 2016 Feb; 15(2):241-50. North America (C.B-17 SCID mice)
  400. Halle B., et al. J Neurooncol. 2016 Jan; 126(1):47-55. Denmark (athymic nude rats)
  401. Debeb B.G., et al. J Natl Cancer Inst. 2016 Apr 13; 108(8). North America (SCID-beige mice)
  402. Hudson K., et al. Mol Cancer Ther. 2016 May; 15(5):877-89. United Kingdom (SCID-beige mice)
  403. Gravekamp, C., et al. (2004). Experimental Biology and Medicine, 229(7), 665-675. North America (BALB/c mice)
  404. Toussaint, M., et al. Theranostics, 2017; 7(2): 436-451. France (athymic nude rat)
  405. Li, R., et. al, Current Cancer Drug Targets, 2014, 14, 274-285. China (athymic nude mouse)

Download our 2017 Product Guide

Oncology model selection infographic - Download your copy here

[Live webinar] Preferential treatment-enrichment options for lab mice and rats